Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma

Clinical trial NCT02504983 · UNKNOWN

Trial details

NCT number: NCT02504983
Sponsor: Chang Gung Memorial Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2015-08-01
Primary completion: 2021-07-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.